SUMMARY A study in gout of the incidence of diagnosis from 1971 to 1975 and of the prevalence at 31 December 1975 was carried out in a representative general practice sample comprising 64 practices and a population numbering 1 in 145 of the total population of Great Britain. The results show an annual incidence in Great Britain from 1971 to 1975 varying from 0 25 to 0 35 per 1000 and an overall prevalence at 31 December 1975 of 2 6 per 1000. The prevalence in England was found to be significantly greater than in the rest of Great Britain and that in Wales to be significantly greater than in Scotland. In 10% of the cases the gout was believed to be secondary, with induction by diuretics being the most frequent cause. The prevalence of primary gout was estimated to be 2 a 3 per 1000.
Little has been published on the frequency of the diagnosis of gouty arthritis in Great Britain. Kellgren et al. (1953) found 6 cases covering a 5-year period in a population of 3515 people, which is a prevalence of 17 per 1000 from the random sample of the population of Leigh in Yorkshire. Popert and Hewitt (1962) CePnsuses and Surveys, 1974) which estimated the number of episodes of gout in England and Wales to be 1 * 8 per 1000 for that year. In addition, from a literature search Kellgren (1964) estimated the prevalence to be less than 3 per 1000 of the population of Europe and North America. Other studies had found similar results with 3 per 1000 in Western Europe (Lawrence, 1960) and 2 8 per 1000 in theUnited States (Wyngaarden and Fredrickson, 1960) , though a result of 15 per 1000 has been found in the group of people followed up in the Framingham study (Hall et al., 1967) . Garrod (1876) raised the question of regional variation by stating that gout was less common in Scotland than England, and, although there are no recorded data, it is a frequently repeated belief (Traut, 1952) . Certainly it is established that the prevalence of gout is much higher in some communities than others. The study by Lennane et Accepted for publication 1 May 1978 Correspondence to Dr W. J. C. Currie, Department of Clinical Research, Merck, Sharp and Dohme, Hoddesdon, Herts. al. (1960) in Roturua showed a prevalence in New Zealanders of European stock of 3 per 1000, while in the Maoris dwelling in the same town it was 27 per 1000.
Methods and materials
Mainly owing to the efforts of the Royal College of General Practitioners a growing number of practices keep E books or some other form of diagnostic index of their patients. A practice without a diagnostic index for coding gout would have to rely heavily on the memory powers of its practitioners and ancillary staff for a list of previously made diagnoses. In view of the vagaries of human memory, it was felt preferable to base the study on actual records. Consequently, random sampling as a selection process was ruled out. It was therefore decided to enlist the help of a group of practices which could provide appropriate records and which would be representative of general practice within Great Britain.
At first contact with each practice the aims of the study were explained and a check was made on the following: (1) The keeping of a diagnostic index; (2) the keeping of an age/sex register; (3) the number of principals in the practice; (4) the practice designation-urban, rural, or mixed; (5) the year of graduation of each doctor with patients in the practice. A list was compiled of all practices stating that they kept a diagnostic index. This was followed up by ascertaining the date when each of these practices 101 began coding gout and whether or not the doctors in each practice were reasonably certain that all such diagnoses had been coded in their diagnostic index. On obtaining satisfactory answers to these 2 questions, the practice was placed on a list from which the final selection was taken.
So that the sample would be of reasonable size it was decided that the total population of the practices selected should not be less than 1 for the urban, rural, mixed comparison. For this principals were over represented (chi squared test purpose it was necessary to use the total complement at 1 % level). The check on the doctors by year of of 201 practitioners within the 64 practices rather graduation showed a similar profile to the National than using only the 160 whose patients were included Health Service statistics with the exception of Scotin the study.
land, where the sample had too many younger By the chi-squared test the urban/rural/mixed doctors (Table 5 ). Monitoring of the age/sex profile split (Table 3 ) gave a good fit for Wales and Scot-of the sample population confirmed that for both land, but showed there to be slightly too many of the sexes the percentage of the sample that fell into each mixed grade in the English practices. By the same of the 4 age groupings (0-14 years, 15-44 years, test the split over size of practice (Table 4) showed 45-64 years, and 65 years and over) was exactly a good fit for each of the 3 countries, but for Great the same for the sample population as for the nation Britain as a whole the practices with 4 or more as a whole. In addition, the measurement of doctors participating by year of graduation when compared with the national picture provided a good fit with the exception of the younger doctors in Scotland, who were in excess of the national picture (Table 5 ).
The year of graduation is not recorded in the official statistics, but the date of birth of each doctor is. For purposes of calculating year of graduation the general rule of assuming graduation at 25 years of age was adopted.
Since certain areas, such as some new towns, have a predominantly young community, while other areas are favoured for retirement, it would be possible for the age/sex structure of the sample not to reflect that of the total population while giving a good fit for the practice and doctor parameters measured. Since the occurrence of gout increases with age, this comparison was deemed important. In the event it provided an excellent fit. Thus the sample was chosen by 2 practice parameters and checked by 2 separate measurements, one involving the doctors and the other the patients. In view of the results it is believed that the sample can be accepted as reasonably, but not totally representative. Since overwhelmingly, doctors equated gout with gouty arthritis, it was felt justifiable to remove the 8 cases which had not experienced acute articular or extraarticular (e.g., bursitis) episodes and thus create a group which was, in that respect, uniform in diagnosis. The prevalence of the diagnosis of gout in Great Britain was shown to be 2-6 per 1000 population, which is in keeping with estimates covering Europe and North America (Lawrence, 1960; Wyngaarden and Fredrickson, 1960; Kellgren, 1964) . Nevertheless the prevalence results are out of step with the Framingham findings (Hall et al., 1967) . On admission to the Framingham study the patients were all in a limited age band of 30-59 years, and at the time of the report in 1967 the mean age was 58 years. The prevalence rates in the over-45-year-old groups for both sexes in this study might be considered a fairer comparison, but even these fall short of the USA results. The male to female prevalence ratio in the Framingham report was 7:1 while in the present study it was found to be 6 1:1. The results (Table 6 ) of the study show a striking difference in the prevalence of the diagnosis of gout in the 3 countries, with Scotland being the lowest at 1 * 3 per 1000 of the study population and England the greatest at 3 0 per 1000 of the study population. Thus the pronouncement of Garrod (1876) and the time-honoured but unproved belief of many physicians since then seems to have been confirmed. Or has it?
That there is a striking difference in the frequency of the diagnosis being made in the 3 countries has been shown, but this is not of necessity the same as the frequency of the disease. However, while most ailments will be both over-and underdiagnosed during the practice of medicine, an examination of the diagnostic pattern (Currie, 1979) and the clinical profile (Currie, 1978) of the gout patients in each of the 3 countries yielded no statistical support for a significant degree of underdiagnosis in Scotland or overdiagnosis in England. Furthermore, a survey by Currie (in preparation) among the doctors in all 3 countries showed no obvious difference in attitude to the diagnosis of gout. It has been noted from population studies in different parts of the world that the frequency of gout and the degree of hyperuricaemia in a community tend to occur somewhat hand in hand (Bremner and Lawrence, 1966) . Therefore it is interesting to note that 2 recent studies (Sturge et al., 1977; Currie, in preparation) have shown no difference in the mean serum uric acid levels of population samples covering England, Wales, and Scotland. Nevertheless, it must equally be stated that the occurrence of clinical gout requires more than just a raised serum uric acid.
No doubt a number of factors are at play in creating the prevalence differences noted, and in this context it is worth remembering that gout has been shown to favour the higher social classes (Popert and Hewitt, 1962; Grahame and Scott, 1970; Currie, 1978) . A statistical examination (chisquared with Yates's correction) of the Economic Activity Tables for Great Britain (Census, 1976) shows that there is a larger proportion of the Scottish community in classes 3, 4, and 5 than in England and Wales (significant at the 0. 1 % level).
Thus gout should be less prevalent in Scotland, although it is doubtful if this could explain the total difference. However, another factor is worthy of comment in this context. The World Health Organisation 's Statistics (1976) show the mortality rate from ischaemic heart disease to be greater in Scotland than in England and Wales. By use of the chisquared test with Yates's correction this difference, for both males and females, is found to be significant at the 0 1 % level. This is by no means new since, Howe (1963) commented on the striking difference between the north and south of Great Britain in the mortality from ischaemic heart disease. Gertler and co-workers (1951) were first to note a statistically significant association of hyperuricaemia and coronary heart disease, and although more recent studies, such as the Framingham Study (Hall et al., 1967) suggest that hyperuricaemia is not a risk factor in ischaemic heart disease, the excess of deaths from ischaemic heart disease within Scotland might selectively reduce the pool of hyperuricaemic potential gout cases in that country.
As would be expected, the incidence of this diagnosis being made in each of the years from 1971 to 1975 in each of the 3 countries varies in line with the prevalence. One factor regarding the incidence figures is that they are relatively high in comparison to the prevalence results, being related by a factor of less than 10. The phenomenon has previously been noted in epidemiological studies (Rose, 1968) .
Of the 966 cases 10% were considered to be secondary gout with diuretic therapy being the most frequent causal agent.
The results of the various regions of England show much variation, with the frequency of the diagnosis occurring more often in the south than in the north and with a peak in the west midlands. Since no attempt was made to ensure that the sample in every region of England was representative of that area, these results should be interpreted with more caution than those for the whole of England.
In both sexes (Table 2) , the prevalence is seen to increase with age, and it is interesting to note that while gout is infrequent in men below 45 years old thereafter the diagnosis occurs in excess of 1 % of the male community. The prevalence in the male is greater at all ages than in the female sex, but it is worth noting that after 44 years the rate of increase of the prevalence in females is considerably greater than in the male-no doubt related to the onset of the menopause with its associated rise in serum uric acid to levels approaching or equal to those in the male (Mikkelsen et al., 1965) . While this is a fairly consistent pattern in all 3 countries, the diagnosis of gout in Welsh females is less than elsewhere, with a resultant higher male to female ratio. Therefore, either the ladies of Wales have some special protection from this malady, or their doctors are less inclined than their English and Scottish counterparts to make the diagnosis in the female sex.
I am indebted to the Royal College of General Practitioners and to many doctors in general practice for unselfishly making this project possible.
